The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan

The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan

Management had named the plan exits, the Medicare margin target and the repricing date before the run began.

UnitedHealth (UNH) Group stock has climbed 65% over the past year, against 22.5% for the S&P 500, 50.6% for peer CVS and 2.4% for peer CI. The easy reading is that a difficult stretch simply ended across managed care. The operating change behind UnitedHealth's own earnings step was more specific, and management had described it, with numbers and a date attached, before the run began.

The Plan Exits Management Named A Year Ago

In late July 2025, before the run began, management said it would exit Medicare Advantage plans then serving over 600,000 members, primarily in less managed products such as PPO offerings. The company was also shifting to narrower networks in Medicare Advantage. Those are not forecasts but operating decisions with a date on them, and they meant 2026 earnings would come from a smaller Medicare book, not a bigger one.

The Margin Target And The Repricing Date Were Public Too

Management sized the prize as well. The stated 2026 target was to expand Medicare margins to a range of 2.5% to 3%, and the timing came with it: about 80% of premium revenue reprices on January 1, so the benefit cuts and pricing actions of mid-2025 would land in one step rather than drift in. The pre-surge financials showed why margin, not volume, was the lever to pull. As of its fiscal Q1 2025 results, trailing-twelve-month revenue of $410.06 billion was growing 8.1%, against an 11.3% average over the three fiscal years through that report.

Revenue Went Nowhere And Operating Earnings Rose 55%

Much of the second quarter of 2026 is that plan arriving. Revenue of $112 billion was largely consistent with the prior year, while operating earnings of $8 billion grew 55% year over year, and the company raised its full-year 2026 outlook. Part of that step, $860 million of it, came from net favorable prior period development, which management says does not change the underlying earnings baseline.

Medicare margins are now expected to finish 2026 above 3%, past the range set before the surge, and full-year Medicare Advantage enrollment is expected to decline by approximately 1.1 million, a wider retreat than the exits management named a year ago. The company earned more by covering fewer people, much as it had said it would. Margin rebuilt from pricing and plan exits rather than from volume is the kind of durable profitability the Trefis High Quality Portfolio looks for in its holdings.

What Was Legible Then, And What Is Still Open In Commercial

So how legible was it? The size of the prize was visible; whether the company would collect it was not. Going into the run, the options market was positioned for a large move in either direction, with implied volatility in the 92nd percentile of its trailing one-year range by the start of August 2025. The second quarter 2026 call points at the unfinished half: commercial medical cost trend is running modestly above 11%, and management says full commercial margin recovery extends past 2027. For the forward version of this setup, a list of companies whose own guidance is climbing is the place to look.

The Medicare Half Has Shown Up, The Commercial Half Has Not

The Medicare repair is already in the reported numbers; what is left to fix is the commercial book, and that is the slower job. The Trefis High Quality Portfolio goes wider, holding a group of quality businesses rather than resting on a single company completing its own turnaround. That portfolio has a track record of outpacing the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000.